Associate Professor David (Dedi) Meiri heads the Laboratory of Cancer Biology and Cannabinoid Research at the Faculty of Biology in the Technion. Dr. Meiri comes from a highly diverse scientific background in biochemistry, plant biotechnology and cancer.

The research conducted in Dr. Meiri’s lab sets out to bridge the gap between herbal and modern medicine. The lab investigates the vast therapeutic potential of secondary metabolites from cannabis and other herbs, algae and psychedelic mushrooms; and reveals how these naturally occurring metabolites affect various types of cancer, inflammatory diseases and disorders of the nervous system such as epilepsy, Alzheimer’s and others. The lab consists of a highly trained team of skilled professionals and students, working in synergy to achieve the highest level of results, to better understand the complexity and diversity of cannabis and other natural components, and realize their full therapeutic potential for human health.

Dr. Meiri is also highly involved in governmental regulations and is a residing member in several Israeli Ministry of Health committees that seek to advance the fundamental understanding of optimal cannabis and other psychedelic plants usage and curtailing adverse effects.